Azenta Life Sciences
Lawrence Lin currently serves as Executive Vice President and Chief Financial Officer at Azenta Life Sciences, a position held since November 2024. Prior experience includes serving as Chief Financial Officer at GeoStabilization International® from September 2022 to November 2024, and as Senior Vice President and Group CFO at PHC Holdings Corporation from February 2021 to August 2022. Additional roles comprise Vice President of Finance for North America and Global Functions at LivaNova, and Vice President of Finance Operations at KaVo Kerr, among others. Lawrence Lin began a professional career with positions at Kerr Corporation and Sybron Dental Specialties, holding various financial leadership roles. Educational background includes a Bachelor of Arts in Finance from California State University, Fullerton.
This person is not in any teams
This person is not in any offices
Azenta Life Sciences
3 followers
Azenta (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research, and advanced cell therapies for the industry's top pharmaceutical, biotech, academic, and healthcare institutions globally.